Search - tctmd.com

Displaying 241 - 260 of 2240

Sort: Relevancy | Date

Presentation TCT 2016

Stent Design and Comprehensive Data Review: Orsiro Cobalt Chromium Sirolimus-Eluting Stents

Presenter: Dean J. Kereiakes, Pieter C. Smits, Thomas Pilgrim

October 30, 2016

Presentation TCT 2016

Stent Design and Comprehensive Data Review: From Nobori to Ultimaster Biolimus-Eluting Stents

Presenter: Dean J. Kereiakes, Pieter C. Smits, Shigeru Saito

October 30, 2016

Presentation TCT 2016

BVS in Primary PCI Using A Robotic Cath Lab System

Presenter: Habib Gamra, Mahmoud Hashemian, Abdullah Shehab, Arif Al Nooryani

October 30, 2016

Presentation TCT 2016

Stent Design and Comprehensive Data Review: BioMatrix Biolimus-Eluting Stents

Presenter: Dean J. Kereiakes, Pieter C. Smits, Stephan Windecker

October 30, 2016

Presentation TCT 2016

Stent Design and Comprehensive Data Review: Resolute Cobalt Chromium Durable Polymer-Based Zotarolimus-Eluting Stents

Presenter: Dean J. Kereiakes, Pieter C. Smits, Roxana Mehran

October 30, 2016

Presentation TCT 2016

Stent Design and Comprehensive Data Review: Platinum Chromium Everolimus-Eluting Stents - Evolution From the Fluoropolymer-Based Promus Element to the Bioabsorbable Polymer-Based Synergy

Presenter: Dean J. Kereiakes, Pieter C. Smits

October 30, 2016

Presentation TCT 2016

Stent Design and Comprehensive Data Review: Xience Cobalt Chromium Fluoropolymer-Based Everolimus-Eluting Stents

Presenter: Dean J. Kereiakes, Pieter C. Smits, Tullio Palmerini

October 30, 2016

Presentation TCT 2016

Current Generation DES and Bioabsorbable Scaffolds

Presenter: Dmitriy N. Feldman, Rajesh V Swaminathan

October 30, 2016

Presentation TCT 2016

LEADERS FREE: Two-Year Clinical and Subgroup Outcomes From a Prospective, Randomized Trial of a Polymer-Free Drug-Coated Stent and a Bare Metal Stent in Patients With Coronary Artery Disease at High Bleeding Risk

Presenter: David W.M. Muller, Jonathan M. Hill, Philip M. Urban

October 30, 2016

News Conference News TCT 2016

LEADERS FREE: Polymer-Free DES Maintains Superior Safety, Efficacy Over BMS at 2 Years

Yael L. Maxwell

October 30, 2016

Presentation TCT 2016

Case Presentations: Heavy Lesion Calcification Is Not a Contraindication for Use of Bioresorbable Scaffolds

Presenter: Mohamed Abdel-Wahab, Philippe Généreux, Manuel Pan

October 30, 2016

Presentation TCT 2016

Case Presentations: Bioresorbable Scaffolds in Bifurcation Lesions How to Do It

Presenter: Antonio Colombo, Gary S. Mintz, Azeem Latib

October 30, 2016

News Conference News TCT 2016

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

Michael O'Riordan

October 30, 2016

Presentation TCT 2016

Stent Embolizations

Presenter: Dimitri Karmpaliotis, Emmanouil S. Brilakis

October 30, 2016

Presentation TCT 2016

ABSORB II: Three-Year Clinical Outcomes From a Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Vascular Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: David W.M. Muller, Jonathan M. Hill, Patrick W. Serruys

October 30, 2016

Presentation TCT 2016

Case Presentations: Knowing When Balloon-Only Lesion Preparation of Calcified Lesions Is Sufficient

Presenter: Mohamed Abdel-Wahab, Philippe Généreux

October 30, 2016

Presentation TCT 2016

Case Presentations: Bioresorbable Scaffolds in STEMI How to Do It

Presenter: Antonio Colombo, Gary S. Mintz, Maurizio Menichelli

October 30, 2016

Presentation TCT 2016

ABSORB China: Two-Year Clinical Outcomes From a Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Vascular Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: David W.M. Muller, Jonathan M. Hill, Runlin Gao

October 30, 2016

Presentation TCT 2016

Case Presentations: Bioresorbable Scaffolds in Diffuse Disease How to Do It

Presenter: Antonio Colombo, Gary S. Mintz, Ashok Seth

October 30, 2016

News Industry News

Study Confirms Polymer-Free Drug-Coated Stents Safer And More Effective Than Bare-Metal Stents In Patients At Risk For Bleeding Treated With One Month Of DAPT

October 30, 2016

Advertisement

Stent Design and Comprehensive Data Review: Orsiro Cobalt Chromium Sirolimus-Eluting Stents

Stent Design and Comprehensive Data Review: From Nobori to Ultimaster Biolimus-Eluting Stents

BVS in Primary PCI Using A Robotic Cath Lab System

Stent Design and Comprehensive Data Review: BioMatrix Biolimus-Eluting Stents

Stent Design and Comprehensive Data Review: Resolute Cobalt Chromium Durable Polymer-Based Zotarolimus-Eluting Stents

Stent Design and Comprehensive Data Review: Platinum Chromium Everolimus-Eluting Stents - Evolution From the Fluoropolymer-Based Promus Element to the Bioabsorbable Polymer-Based Synergy

Stent Design and Comprehensive Data Review: Xience Cobalt Chromium Fluoropolymer-Based Everolimus-Eluting Stents

Current Generation DES and Bioabsorbable Scaffolds

LEADERS FREE: Two-Year Clinical and Subgroup Outcomes From a Prospective, Randomized Trial of a Polymer-Free Drug-Coated Stent and a Bare Metal Stent in Patients With Coronary Artery Disease at High Bleeding Risk

LEADERS FREE: Polymer-Free DES Maintains Superior Safety, Efficacy Over BMS at 2 Years

Case Presentations: Heavy Lesion Calcification Is Not a Contraindication for Use of Bioresorbable Scaffolds

Case Presentations: Bioresorbable Scaffolds in Bifurcation Lesions How to Do It

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

Stent Embolizations

ABSORB II: Three-Year Clinical Outcomes From a Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Vascular Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Case Presentations: Knowing When Balloon-Only Lesion Preparation of Calcified Lesions Is Sufficient

Case Presentations: Bioresorbable Scaffolds in STEMI How to Do It

ABSORB China: Two-Year Clinical Outcomes From a Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Vascular Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Case Presentations: Bioresorbable Scaffolds in Diffuse Disease How to Do It

Study Confirms Polymer-Free Drug-Coated Stents Safer And More Effective Than Bare-Metal Stents In Patients At Risk For Bleeding Treated With One Month Of DAPT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content